Sinopharm Group Co Top Insiders

SHTDFDelisted Stock  USD 2.70  0.00  0.00%   
Sinopharm Group employs about 113.2 K people. The company is managed by 8 executives with a total tenure of roughly 57 years, averaging almost 7.0 years of service per executive, having 14154.25 employees per reported executive. Examination of Sinopharm Group's management performance can provide insight into the company performance.
Shuangjun Xu  President
Vice President
Maisong Cai  President
Vice President
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Sinopharm Group Management Team Effectiveness

The company has return on total asset (ROA) of 0.0364 % which means that it generated a profit of $0.0364 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1319 %, meaning that it generated $0.1319 on every $100 dollars invested by stockholders. Sinopharm Group's management efficiency ratios could be used to measure how well Sinopharm Group manages its routine affairs as well as how well it operates its assets and liabilities.

Sinopharm Group Workforce Comparison

Sinopharm Group Co is currently regarded as top stock in number of employees category among its peers. The total workforce of Medical Distribution industry is at this time estimated at about 358,814. Sinopharm Group totals roughly 113,234 in number of employees claiming about 32% of all equities under Medical Distribution industry.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04.

Sinopharm Group Notable Stakeholders

A Sinopharm Group stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sinopharm Group often face trade-offs trying to please all of them. Sinopharm Group's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sinopharm Group's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Shuangjun XuVice PresidentProfile
Maisong CaiVice PresidentProfile
Xiuchang JiangCFO VPProfile
Yijian WuNon-Executive DirectorProfile
Qingming YuExecutive DirectorProfile
Yong LiuChief Legal Advisor and VPProfile
Xiaojuan LiChief OfficerProfile
Wanyong LianSupervisorProfile

About Sinopharm Group Management Performance

The success or failure of an entity such as Sinopharm Group often depends on how effective the management is. Sinopharm Group management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sinopharm management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sinopharm management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm Group is traded on OTC Exchange in the United States.

Sinopharm Group Workforce Analysis

Traditionally, organizations such as Sinopharm Group use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sinopharm Group within its industry.

Sinopharm Group Manpower Efficiency

Return on Sinopharm Group Manpower

Revenue Per Employee4.6M
Revenue Per Executive65.1B
Net Income Per Employee68.5K
Net Income Per Executive969.8M
Working Capital Per Employee284.9K
Working Capital Per Executive4B
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Sinopharm Pink Sheet

If you are still planning to invest in Sinopharm Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sinopharm Group's history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data